|
Satayathum, Sudtida A; Muchiri, Eric M; Ouma, John H et al. (2006) Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program. Am J Trop Med Hyg 75:83-92
|
|
King, Charles H (2006) Long-term outcomes of school-based treatment for control of urinary schistosomiasis: a review of experience in Coast Province, Kenya. Mem Inst Oswaldo Cruz 101 Suppl 1:299-306
|
|
Kim, Mikyung; Qiao, Zhi-Song; Montefiori, David C et al. (2005) Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies. AIDS Res Hum Retroviruses 21:58-67
|
|
Liao, Hua-Xin; Alam, S Munir; Mascola, John R et al. (2004) Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins. J Virol 78:5270-8
|
|
Long, Timothy E (2003) Recent progress toward the clinical development of new anti-MRSA antibiotics. IDrugs 6:351-9
|
|
Li, Z; King, C L; Ogundipe, J O et al. (1995) Preferential recognition by human IgE and IgG4 of a species-specific Schistosoma haematobium serine protease inhibitor. J Infect Dis 171:416-22
|
|
Pearlman, E; Heinzel, F P; Hazlett Jr, F E et al. (1995) IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi. J Immunol 154:4658-64
|
|
King, C L; Hakimi, J; Shata, M T et al. (1995) IL-12 regulation of parasite antigen-driven IgE production in human helminth infections. J Immunol 155:454-61
|
|
King, C L; Stupi, R J; Craighead, N et al. (1995) CD28 activation promotes Th2 subset differentiation by human CD4+ cells. Eur J Immunol 25:587-95
|
|
Blanton, R E; Licate, L S; Aman, R A (1994) Characterization of a native and recombinant Schistosoma haematobium serine protease inhibitor gene product. Mol Biochem Parasitol 63:1-11
|
Showing the most recent 10 out of 77 publications
